Objective: The aim of this study was to modify the Chinese version of the Menopause Symptom Assessment Scale (MSAS) and evaluate its validity and reliability.
Methods: An expert panel from the gynecology and nursing domain determined items that should remain or be revised, and 30 participants were selected for the pilot study. A total of 255 women who met the criteria for inclusion were enrolled in the investigation. SPSS 25.0 and AMOS 25.0 were used to analyze data. The internal and external reliability of the scale was evaluated using Cronbach's α coefficient, split-half reliability, and test-retest reliability, respectively. Expert review, exploratory factor analysis, and confirmatory factor analysis were used to evaluate the scale's validity, which encompasses both its content validity and structural validity.
Results: The Chinese version of the MSAS contains 43 items with 5 dimensions, including sexual function, psychological status, interpersonal anxiety, autonomic balance, and other subjective symptoms. The correlation coefficient (r value) between individual items and the total scale ranged from 0.49 to 0.67 (P < 0.05); the Item-Content Validity Index range from 0.80 to 1.00, and Scale-Content Validity Index was 0.91; the Cronbach's α coefficient was 0.85, and the test-retest reliability was 0.93; exploratory factor analysis revealed a cumulative variance contribution of 76.98%; the fitting index of the scale structure model was good.
Conclusions: The updated Chinese version of the MSAS presented good reliability and validity and could be applied in assessing menopausal symptoms in Chinese women.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/GME.0000000000002458 | DOI Listing |
Endocrine
December 2024
Department of Encephalopathy, The Affiliated Hospital of Changchun University of Chinese Medicine, Jilin, China.
Objectives: With the prolongation of life expectancy in patients with myasthenia gravis, the number of comorbidities is increasing. Diabetes mellitus is one of the main comorbidities faced by patients with myasthenia gravis. However, there is not enough epidemiological information on diabetes mellitus.
View Article and Find Full Text PDFMenopause
January 2025
From the Department of Quality Control, Yuebei People's Hospital, Shantou University Medical College, Shaoguan, China.
Objective: The aim of this study was to modify the Chinese version of the Menopause Symptom Assessment Scale (MSAS) and evaluate its validity and reliability.
Methods: An expert panel from the gynecology and nursing domain determined items that should remain or be revised, and 30 participants were selected for the pilot study. A total of 255 women who met the criteria for inclusion were enrolled in the investigation.
Int J Surg
December 2024
Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Background: We aimed to assess the efficacy and feasibility of applying patient-reported outcome (PRO) based symptom management in the early postoperative period after breast cancer surgery.
Materials And Method: Before surgery, patients diagnosed with breast cancer who met the inclusion criteria were randomly assigned in a 1:1 ratio to receive either postoperative PRO-based symptom management or usual care. All patients completed the MD Anderson Symptom Inventory-Chinese version (MDASI-C) via the electronic PRO system preoperatively, on a daily basis postoperatively, and twice weekly after discharge, for a duration up to 2 weeks.
Patient Relat Outcome Meas
December 2024
School of Humanities and Management Science, Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
Introduction: To develop and psychometrically validate the Self-management Questionnaire for Patients with Lower Extremity Arterial Disease Patients Who Underwent Endovascular Revascularization (LESQ).
Methods: We developed the LESQ and validated it in a Chinese population. A three-round cross-sectional descriptive survey in six hospitals in China, involving samples of 271, 269, and 623 participants, respectively.
Syst Rev
December 2024
West China Center of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Background: Sepsis is a life-threatening organ dysfunction with high morbidity and mortality. Various studies have demonstrated the effectiveness of Chinese tonic medicines (CTMs) in treating sepsis or septic shock. However, trials directly comparing the efficacy and safety of different CTMs for sepsis or septic shock are still lacking.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!